Volume | 54,909 |
|
|||||
News | (1) | ||||||
Day High | 27.092 | Low High |
|||||
Day Low | 26.22 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
SurModics Inc | SRDX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
26.24 | 26.22 | 27.092 | 26.49 | 26.39 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,242 | 54,909 | $ 26.44 | $ 1,451,593 | - | 16.79 - 39.41 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:03:20 | priorref | 139 | $ 26.49 | USD |
SurModics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
376.97M | 14.24M | - | 133.41M | -1.54M | -0.11 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
SurModics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRDX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 27.54 | 27.97 | 26.22 | 26.53 | 209,831 | -1.05 | -3.81% |
1 Month | 28.35 | 29.78 | 26.22 | 27.00 | 103,301 | -1.86 | -6.56% |
3 Months | 34.91 | 37.50 | 26.22 | 28.97 | 63,921 | -8.42 | -24.12% |
6 Months | 29.68 | 39.24 | 26.22 | 31.70 | 68,327 | -3.19 | -10.75% |
1 Year | 23.00 | 39.41 | 16.79 | 30.08 | 72,801 | 3.49 | 15.17% |
3 Years | 57.95 | 62.27 | 16.00 | 33.24 | 65,642 | -31.46 | -54.29% |
5 Years | 42.22 | 62.27 | 16.00 | 36.75 | 67,799 | -15.73 | -37.26% |
SurModics Description
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using our technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit and the Vitro diagnostics unit. Surmodics derives most of its revenue from the Vitro diagnostics segment. |